Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Faisal N Alotaibi"'
Autor:
Adel S Alharbi, Abdullah A Yousef, Saleh A Alharbi, Abdullah Al-Shamrani, Mansour M Alqwaiee, Mohammed Almeziny, Yazan S Said, Saleh Ali Alshehri, Faisal N Alotaibi, Rafat Mosalli, Khaled Ali Alawam, Muslim M Alsaadi
Publikováno v:
Annals of Thoracic Medicine, Vol 16, Iss 2, Pp 188-218 (2021)
The Saudi Pediatric Pulmonology Association (SPPA) is a subsidiary of the Saudi Thoracic Society (STS), which consists of a group of Saudi experts with well-respected academic and clinical backgrounds in the fields of asthma and other respiratory dis
Externí odkaz:
https://doaj.org/article/7f70b705c8b14661b9b0f6aa69a5de3e
Autor:
Adel S. Alharbi, Abdullah A. Yousef, Saleh A. Alharbi, Talal M. Almaghamsi, Mansour M. Al Qwaiee, Faisal M. Al-Somali, Turki S. Alahmadi, Sami A. Alhaider, Wadha H. Alotaibi, Mona A. Albalawi, Faisal N. Alotaibi, Ahmed S. Alenizi, Muslim M. Alsaadi, Yazan S. Said
Publikováno v:
Saudi Medical Journal. 43:329-340
In Saudi Arabia, the prevalence of pediatric asthma ranges between 8% and 25%. However, there are no sufficient data regarding severe asthma in childhood in Saudi Arabia. Therefore, a task force has been formed by the Saudi Pediatric Pulmonology Asso
Autor:
Faisal N Alotaibi, Mohammed Alswayyed, Ahmed Z Alanazi, Wael A. Alanazi, Khaldoon Aljerian, Homood M. As Sobeai, Ali Alhoshani, Moureq R. Alotaibi, Khalid Alhazzani
Publikováno v:
Journal of Biochemical and Molecular Toxicology. 35
Doxorubicin (DOX) treatment has been associated with cardiotoxicity. Therefore, it is crucial to search for a therapeutic that can effectively mitigate DOX-induced cardiotoxicity. This study was conducted to investigate the protective effects of vals